FRM
SRNE

Fox Run Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Fox Run Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,701
Closed -$68K – 769
2021
Q4 		$68K Buy
+14,701
New +$68K 0.04% 434
2021
Q1 		– Sell
-13,638
Closed -$93K – 336
2020
Q4 		$93K Buy
+13,638
New +$93K 0.19% 178